English regulators have lifted restrictions on another bispecific antibody, improving treatment choices for patients with multiple myeloma.
Elranatamab is now likely to be used for the treatment of about 700 patients a year in England, the Nationa...
6 months ago
Scientists have found features in CAR-T therapies that may help predict their effectiveness in patients.
The Spanish research team studied a CAR-T therapy in use against B-cell acute lymphoblastic leukaemia, varnimcabtagene autoleucel. They studie...
6 months ago
